Comparative study finds early vision benefits for intravitreal triamcinolonetreatment of occult CNV

May 5, 2003

Ft. Lauderdale-Results from a prospective, comparative study indicateintravitreal triamcinolone acetonide 25 mg may improve visual outcome insome patients with exudative AMD, reported Jost B. Jonas, MD, of the Universityof Heidelberg, Germany.